172 related articles for article (PubMed ID: 2869578)
1. Future treatment of peptic ulcers.
Calam J
Scand J Gastroenterol Suppl; 1985; 117():47-53. PubMed ID: 2869578
[TBL] [Abstract][Full Text] [Related]
2. [Progress in the pharmacotherapy of peptic ulcer].
Stasiewicz J; Moniuszko-Jakoniuk J
Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1721-5. PubMed ID: 6151657
[No Abstract] [Full Text] [Related]
3. Peptic ulcer disease, cytoprotection, and prostaglandins.
Fiske SC
Arch Intern Med; 1988 Oct; 148(10):2112-3. PubMed ID: 3140751
[No Abstract] [Full Text] [Related]
4. Prostaglandins for peptic ulcer: a promise unfulfilled.
Hawkey CJ; Walt RP
Lancet; 1986 Nov; 2(8515):1084-7. PubMed ID: 2877235
[TBL] [Abstract][Full Text] [Related]
5. [Importance of acid secretion inhibition in peptic ulcer treatment].
Med Clin (Barc); 1990 Mar; 94(8):suppl 2 p.. PubMed ID: 2342387
[No Abstract] [Full Text] [Related]
6. Some problems in modern anti-ulcer drug evaluation: a comparison of four gastric acid suppressors.
Gibinski K
Curr Med Res Opin; 1981; 7(8):516-9. PubMed ID: 6273068
[TBL] [Abstract][Full Text] [Related]
7. The mode of action of colloidal bismuth subcitrate.
Lee SP
Scand J Gastroenterol Suppl; 1991; 185():1-6. PubMed ID: 1957120
[TBL] [Abstract][Full Text] [Related]
8. [Role of prostanoids in the pathogenesis and therapy of peptic ulcer].
Fich A; Stalnikowicz R; Goldin E; Eliakim R; Wengrower D; Ligumsky M; Karmeli F; Rachmilewitz D
Harefuah; 1986 Nov; 111(10):292-5. PubMed ID: 3817615
[No Abstract] [Full Text] [Related]
9. Prostaglandins and peptic ulcer therapy.
Walt RP
Scand J Gastroenterol Suppl; 1990; 174():29-36. PubMed ID: 1976271
[TBL] [Abstract][Full Text] [Related]
10. [Therapy and prevention of peptic lesions by prostaglandins].
Müller P; Dammann HG; Simon B
Z Gastroenterol; 1987 Aug; 25 Suppl 3():166-74. PubMed ID: 3116777
[TBL] [Abstract][Full Text] [Related]
11. There is more to healing ulcers than suppressing acid.
Colin-Jones DG
Gut; 1986 May; 27(5):475-80. PubMed ID: 3084343
[No Abstract] [Full Text] [Related]
12. Is smoking still important in the pathogenesis of peptic ulcer disease?
Eastwood GL
J Clin Gastroenterol; 1997; 25 Suppl 1():S1-7. PubMed ID: 9479620
[TBL] [Abstract][Full Text] [Related]
13. Antisecretory and mucosal protective actions of misoprostol. Potential role in the treatment of peptic ulcer disease.
Wilson DE
Am J Med; 1987 Jul; 83(1A):2-8. PubMed ID: 3113241
[TBL] [Abstract][Full Text] [Related]
14. Advances in drug therapy for peptic ulcer disease.
Pappas TN; Mulvihill SJ; Goto Y; Debas HT
Arch Surg; 1987 Apr; 122(4):447-50. PubMed ID: 2882741
[TBL] [Abstract][Full Text] [Related]
15. Peptic ulcer disease.
Hawker P
Practitioner; 1989 May; 233(1469):769-70, 773. PubMed ID: 2602318
[TBL] [Abstract][Full Text] [Related]
16. Peptic ulcer--current status.
Brooks FP
Clin Invest Med; 1987 May; 10(3):108-16. PubMed ID: 3113795
[TBL] [Abstract][Full Text] [Related]
17. [New prostaglandin derivatives--progress in ulcer therapy?].
Schepp W
Fortschr Med; 1986 Dec; 104(3):913-7. PubMed ID: 2881863
[No Abstract] [Full Text] [Related]
18. Growth factors: new 'endogenous drugs' for ulcer healing.
Szabo S; Kusstatscher S; Sakoulas G; Sandor Z; Vincze A; Jadus M
Scand J Gastroenterol Suppl; 1995; 210():15-8. PubMed ID: 8578198
[TBL] [Abstract][Full Text] [Related]
19. Assessing the safety of drugs for the long-term treatment of peptic ulcers.
Wormsley KG
Gut; 1984 Dec; 25(12):1416-23. PubMed ID: 6150883
[No Abstract] [Full Text] [Related]
20. Current concepts in clinical therapeutics: peptic ulcer disease.
Siepler JK; Mahakian K; Trudeau WT
Clin Pharm; 1986 Feb; 5(2):128-42. PubMed ID: 2869852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
